European Overview
The European cannabis industry has seen transformative change throughout 2024 and the beginning of 2025, marked by significant milestones in both medical and adult-use cannabis markets. It is forecasted that total sales of the European cannabis market (medical, adult-use & CBD) in 2025 will reach XXX – Click here to find out more about premium data packages, including market sizing forecasts.
Following the adoption of the new cannabis regulations on 1 April 2024, Germany’s medical cannabis market has undergone explosive growth, with new market structures developing. In parallel to the medical overhaul, adult-use cannabis cultivation associations have been established in various federal states in Germany. Uncertainty now surrounds the adult-use pilot programmes, intended to be rolled out as part of the second pillar of the country’s cannabis legalisation framework, following the conservative CDU/CSU party coming into government.
The Swiss adult-use trial programme is in full swing, with seven active trials ongoing across the country. Full results from the trials have not been published, but preliminary signs are positive. A proposal for full legalisation for the production and sale of adult-use cannabis in Switzerland is in early stages of development, having been adopted by the National Council. A preliminary draft of the new law will be drawn up in the coming months.
Medical cannabis production is ramping up across Europe, with countries including the Czech Republic, Denmark, Spain, Portugal and North Macedonia seeing significant cultivation and export quantities. Furthermore, Germany and the UK are quickly becoming European powerhouses in the manufacturing and processing of medical cannabis extract products. Following years of medical cannabis pilot programs in Denmark and France, both countries are now concretely moving towards establishing permanent medical cannabis frameworks within their respective healthcare systems.
Medical
Legalisation Map
Click on a country and then click ‘Read More’ for country-level insights.
No Market
Restricted Market
Small/Slow Market
Free Market
Market in Transition
Pilot Programme
Small/Growing Market
Tightly Controlled Market
Adult-Use Map
Click on a country and then click ‘Read More’ for country-level insights.
Cannabis Associations
& Home Cultivation
(Planned Pilot Projects)
Cannabis Associations
& Home Cultivation
Home Cultivation Only
Commerical Pilot
Programme(s)
CBD Map
No Market
Very High Level of Tolerance
High Level of Tolerance
Medium Level of Tolerance
Low Level of Tolerance
